Asymptomatic Primary Hyperparathyroidism: A Prospective, Randomized Trial (SIPH)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00522028|
Recruitment Status : Completed
First Posted : August 29, 2007
Last Update Posted : May 23, 2016
|Condition or disease|
The patients are included and randomized by block randomization to medical observation or parathyroidectomy by an experienced parathyroid surgeon.
The patients will be followed up for 10 years.
|Study Type :||Observational|
|Actual Enrollment :||191 participants|
|Official Title:||Asymptomatic Primary Hyperparathyroidism: A Prospective, Randomized Trial|
|Study Start Date :||October 1998|
|Primary Completion Date :||January 2016|
|Study Completion Date :||January 2016|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00522028
|Oslo University Hospital - Rikshospitalet|
|Oslo, Norway, 0027|
|Principal Investigator:||Jens Bollerslev, MD||Rikshospitalet University Hospital|